Free. Unsubscribe any time.
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. filed 52 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 138 transactions and 7,639,392 shares. 44 carry the SEC's AFF10B5ONE flag; 8 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-08, came on the same day as the one before it (2026-09-08) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 1,085 shares, 3,950 fewer than the 5,035 in the filing before it.
- Its 52 plan statements rank 102nd of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 52 filings on file run from 2025-02-18 to 2026-09-08, and state 2 plan adoption dates, from 2026-03-19 to 2026-07-13.
Trades in Dyne Therapeutics, Inc. 138
- Beskrovnaya Oxana — 2025-02-18 · S · 2,598 shares
- Scalzo Richard William — 2025-02-18 · S · 2,488 shares
- Beskrovnaya Oxana — 2025-03-05 · S · 1,094 shares
- Cox John — 2025-03-05 · S · 4,061 shares
- Kerr Douglas — 2025-03-05 · S · 1,343 shares
- Scalzo Richard William — 2025-03-05 · S · 917 shares
- Beskrovnaya Oxana — 2025-03-11 · S · 2,153 shares
- Scalzo Richard William — 2025-03-11 · S · 1,343 shares
- Friedl-Naderer Johanna — 2025-03-13 · S · 143 shares
- Cox John — 2025-06-05 · S · 4,060 shares
- Friedl-Naderer Johanna — 2025-06-05 · S · 146 shares
- Kerr Douglas — 2025-06-05 · S · 1,342 shares
Adoption dates in Dyne Therapeutics, Inc. 2
- 2026-03-19 — stated in 7 filings
- 2026-07-13 — stated in 1 filing
Results prints in Dyne Therapeutics, Inc. 9
- 2025-01-10
- 2025-02-27
- 2025-05-08
- 2025-07-28
- 2025-11-05
- 2026-01-12
- 2026-03-02
- 2026-05-11
- 2026-07-29
Trades before a print in Dyne Therapeutics, Inc. 6
- 2 days before the 2026-07-29 print — 2026-07-27 · S · Kersten Dirk · 256,072 shares
- 2 days before the 2026-07-29 print — 2026-07-27 · S · Kersten Dirk · 5,388 shares
- 5 days before the 2026-05-11 print — 2026-05-06 · S · Rhodes Jason P · 21,926 shares
- 5 days before the 2026-05-11 print — 2026-05-06 · S · Rhodes Jason P · 43,621 shares
- 5 days before the 2026-05-11 print — 2026-05-06 · S · Rhodes Jason P · 428 shares
- 5 days before the 2026-05-11 print — 2026-05-06 · S · Rhodes Jason P · 17,244 shares
- 6 days before the 2026-05-11 print — 2026-05-05 · S · Rhodes Jason P · 3,056 shares
- 6 days before the 2026-05-11 print — 2026-05-05 · S · Rhodes Jason P · 6,081 shares
- 6 days before the 2026-05-11 print — 2026-05-05 · S · Rhodes Jason P · 60 shares
- 6 days before the 2026-05-11 print — 2026-05-05 · S · Rhodes Jason P · 2,403 shares
- 7 days before the 2026-05-11 print — 2026-05-04 · S · Rhodes Jason P · 3,136 shares
- 7 days before the 2026-05-11 print — 2026-05-04 · S · Rhodes Jason P · 6,241 shares
Interval to Dyne Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 6within 5 days
- 16within 10 days
- 2shortest, days
- 15no later print
- Beskrovnaya Oxana 2025-02-18 · S · 9 days before the 2025-02-27 print · Chief Scientific Officer
- Scalzo Richard William 2025-02-18 · S · 9 days before the 2025-02-27 print · SVP, Head of Finance & Admin.
- Rhodes Jason P 2026-05-04 · S · 7 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-04 · S · 7 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-04 · S · 7 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-04 · S · 7 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-05 · S · 6 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-05 · S · 6 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-05 · S · 6 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-05 · S · 6 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-06 · S · 5 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-06 · S · 5 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-06 · S · 5 days before the 2026-05-11 print
- Rhodes Jason P 2026-05-06 · S · 5 days before the 2026-05-11 print
- Kersten Dirk 2026-07-27 · S · 2 days before the 2026-07-29 print
- Kersten Dirk 2026-07-27 · S · 2 days before the 2026-07-29 print
Adoption dates Dyne Therapeutics, Inc. states
- 2026-03-19 in 7 filings
- 2026-07-13 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 19, 2026”
Reported results dates on file
- 2025-01-10
- 2025-02-27
- 2025-05-08
- 2025-07-28
- 2025-11-05
- 2026-01-12
- 2026-03-02
- 2026-05-11
- 2026-07-29
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.